Literature DB >> 3872635

Anti-Ro(SSA) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects.

H M Moutsopoulos, F N Skopouli, A K Sarras, C Tsampoulas, A K Mavridis, S H Constantopoulos, P J Maddison.   

Abstract

The clinical, laboratory, histological, and radiological manifestations of 90 Greek patients with anti-Ro(SSA) negative rheumatoid arthritis (RA) were compared with those of 15 Greek patients with anti-Ro(SSA) positive RA. Anti-Ro(SSA) positive RA patients had the same articular and extra-articular manifestations as anti-Ro(SSA) negative patients. However, they were predominantly females with lower rheumatoid factor titres and a high incidence of positive minor salivary gland biopsy specimens for Sjögren's syndrome. Finally, anti-Ro(SSA) positive RA patients frequently experienced penicillamine side effects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3872635      PMCID: PMC1001615          DOI: 10.1136/ard.44.4.215

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  21 in total

1.  Resolution of the identity of certain antigen-antibody systems in systemic lupus erythematosus and Sjögren's syndrome: an interlaboratory collaboration.

Authors:  M Alspaugh; P Maddison
Journal:  Arthritis Rheum       Date:  1979-07

2.  Differentiation and characterization of autoantibodies and their antigens in Sjögren's syndrome.

Authors:  M A Alspaugh; N Talal; E M Tan
Journal:  Arthritis Rheum       Date:  1976 Mar-Apr

3.  Minor salivary gland involvement in Sjögren's syndrome.

Authors:  T M Tarpley; L G Anderson; C L White
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1974-01

4.  Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus.

Authors:  G Clark; M Reichlin; T B Tomasi
Journal:  J Immunol       Date:  1969-01       Impact factor: 5.422

5.  Antibody to a soluble acidic nuclear antigen in Sjögren's syndrome.

Authors:  S S Kassan; M Akizuki; A D Steinberg; R L Reddick; T M Chused
Journal:  Am J Med       Date:  1977-09       Impact factor: 4.965

6.  Standardized respiratory questionnaires: comparison of the old with the new.

Authors:  G W Comstock; M S Tockman; K J Helsing; K M Hennesy
Journal:  Am Rev Respir Dis       Date:  1979-01

7.  Association of the B-cell alloantigen DRw4 with rheumatoid arthritis.

Authors:  P Stastny
Journal:  N Engl J Med       Date:  1978-04-20       Impact factor: 91.245

8.  The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue diseases.

Authors:  P Maddison; H Mogavero; T T Provost; M Reichlin
Journal:  J Rheumatol       Date:  1979 Mar-Apr       Impact factor: 4.666

9.  Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs.

Authors:  G S Panayi; P Wooley; J R Batchelor
Journal:  Br Med J       Date:  1978-11-11

10.  The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: synergistic inhibition by D-penicillamine and copper salts.

Authors:  P E Lipsky; M Ziff
Journal:  J Immunol       Date:  1978-03       Impact factor: 5.422

View more
  14 in total

1.  Rheumatoid arthritis in Greece. Manifestations in different age groups.

Authors:  A P Andonopoulos; V Galanopoulou; A A Drosos; H M Moutsopoulos
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

2.  Psychological distress and personality traits in early rheumatoid arthritis: A preliminary survey.

Authors:  T N Hyphantis; M Bai; V Siafaka; A N Georgiadis; P V Voulgari; V Mavreas; A A Drosos
Journal:  Rheumatol Int       Date:  2005-12-09       Impact factor: 2.631

3.  Multiple tendon ruptures in a patient affected by anti-SSA/Ro antibody positive rheumatoid arthritis.

Authors:  P Caramaschi; D Biasi; A Carletto; T Manzo; M Randon; M L Pacor; L M Bambara
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980

4.  Anti-Ro positive rheumatoid arthritis.

Authors:  I Stewart; J C Ridway
Journal:  Ann Rheum Dis       Date:  1986-01       Impact factor: 19.103

5.  Chronic destructive monoarthritis of the wrist in patients with anti-SSA/Ro antibodies: report of two cases.

Authors:  M Satoh; H Yamagata; F Watanabe; Y Matsushita; S Nakayama; K Okubo; M Akizuki
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

6.  Lack of HLA-antigen association in Greek rheumatoid arthritis patients.

Authors:  C A Papasteriades; I D Kappou; F N Skopouli; M N Barla; G A Fostiropoulos; H M Moutsopoulos
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

7.  TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved.

Authors:  Anthony H Keeble; Zahra Khan; Alan Forster; Leo C James
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-17       Impact factor: 11.205

8.  Rheumatoid factors in Ro (SSA) positive and Ro (SSA) negative rheumatoid arthritis patients.

Authors:  A E Gharavi; F N Skopouli; B M Patel; G R Hughes; H M Moutsopoulos
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

9.  Unusual eye manifestations in systemic lupus erythematosus patients.

Authors:  A A Drosos; C A Petris; G M Petroutsos; H M Moutsopoulos
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

10.  Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function.

Authors:  Leo C James; Anthony H Keeble; Zahra Khan; David A Rhodes; John Trowsdale
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.